Review of the pharmacological and bariatric surgery for diabesity

@inproceedings{Gruchy2017ReviewOT,
  title={Review of the pharmacological and bariatric surgery for diabesity},
  author={Emmeline de Gruchy and Vinay Somashekar Eligar},
  year={2017}
}
impaired,2” as is the case in T2DM where obesity compounds disease progression.3,4 Obesity contributes to insulin resistance,5 and as such addressing obesity is a vital aspect in the management of T2DM.6 Moderate and maintained weight loss has been demonstrated to be effective in lowering glycaemic levels in obese people with T2DM as well as reducing the need for oral hypoglycaemic medications.7 T2DM guidelines recommend lifestyle interventions as first line management for obesity yet despite… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 28 REFERENCES

Liraglutide and obesity: a review of the data so far

  • Drug design, development and therapy
  • 2015
VIEW 1 EXCERPT
HIGHLY INFLUENTIAL

Similar Papers

Loading similar papers…